Results 131 to 140 of about 69,560 (333)

Overview of Anemia Among Systemic Lupus Erythematosus Patients in Reproductive Age Women Based on Reticulocyte Hemoglobin Equivalent (RET-He) Level and Reticulocyte Count [PDF]

open access: yes, 2017
Background: Anemia is a common manifestation found among patients with Systemic Lupus Erythematosus (SLE). It may be caused by iron-deficiency, autoimmune hemolytic, and chronic inflammation. Each anemia has different therapy approachments.
Ghozali, M. (Mohammad)   +3 more
core  

Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome [PDF]

open access: yes, 2010
Thrombotic microangiopathies (TMAs) are pathological conditions characterized by generalized microvascular occlusion by platelet thrombi, thrombocytopenia, and microangiopathic hemolytic anemia.
Mastroianni Kirsztajn, Gianna   +1 more
core   +2 more sources

Association Between Oral Lichen Planus and Non‐Oral Cancers: A Multicentre Case–Control SIPMO Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives This multicentre case–control study aimed to investigate the potential association between oral lichen planus (OLP) and extraoral cancers. The secondary objective included the identification of risk factors for this association. Methods The study was conducted between January 2023 and June 2024 and included 21 Italian Oral Medicine ...
Gioele Gioco   +62 more
wiley   +1 more source

Vitiligo and autoimmune thyroid disorders [PDF]

open access: yes, 2017
Vitiligo represents the most common cause of acquired skin, hair and oral depigmentation, affecting 0.5-1% of the population worldwide. It is clinically characterized by the appearance of disfiguring circumscribed skin macules following melanocyte ...
Baldini, Enke   +10 more
core   +2 more sources

Autoantibodies in COVID‐19 convalescent plasma donors

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Although COVID‐19 convalescent plasma (CCP) has been successfully used to treat several viral infections, its effectiveness in neutralizing severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and its broader immunological safety remain debated.
Katerina Jazbec Gradišar   +5 more
wiley   +1 more source

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors

open access: yesAmerican journal of hematology/oncology, 2019
Immune checkpoint inhibitors (ICPis) are a novel class of immunotherapeutic agents that have revolutionized the treatment of cancer; however, these drugs can also cause a unique spectrum of autoimmune toxicity.
R. K. Leaf   +17 more
semanticscholar   +1 more source

Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2020
xx
F. Hindilerden   +4 more
semanticscholar   +1 more source

Modulators of Diacylglycerol Kinase Activity: A Review of Advances and Challenges

open access: yesMedicinal Research Reviews, Volume 46, Issue 1, Page 149-175, January 2026.
ABSTRACT Catalyzing the conversion of diacylglycerol (DAG) in phosphatidic acid (PA), diacylglycerol kinases (DGKs) play a pivotal role in all the physiological processes modulated by these two bioactive lipids, such as lipid metabolism and immune regulation.
Luisa Racca   +2 more
wiley   +1 more source

Marked efficacy of Rituximab in multifocal motor neuropathy associated with chronic lymphocytic leukemia [PDF]

open access: yes, 2016
The authors describe a patient who presented a multifocal motor neuropathy (MMN) associated with a high anti-ganglioside antibody (anti-GM1 and anti-GD1) titer at the clinical onset of a B-cell chronic lymphocytic leukemia (B-CLL). Immunomodulation (IVIg
Antonella Di, Pasquale   +6 more
core  

Home - About - Disclaimer - Privacy